Use of pde inhibitors in the manufacture of a medicament for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/475 (2006.01) A61K 31/136 (2006.01) A61K 31/435 (2006.01) A61K 31/4375 (2006.01) A61K 31/52 (2006.01) A61K 31/5415 (2006.01) C12Q 1/44 (2006.01)

Patent

CA 2228314

The present invention pertains to the use of inhibitors of phosphodiesterase I for the treatment of urinary bladder diseases, in particular the use of vincamine, vinpocetine (ethyl apovincamin-22-oate), and/or modified compounds of the said inhibitors having inhibiting properties for PDE I, as well as pharmacologically compatible salts thereof, in local and systemic administration.

La présente invention se rapporte à l'utilisation d'inhibiteurs de la phosphodiestérase I (PDE I) dans le traitement de maladies de la vessie urinaire, et notamment à l'utilisation de vincamine, de vinpocétine (éthyl apovincamine-22-oate), et/ou de composés modifiés de tels inhibiteurs qui présentent des caractéristiques d'inhibition de la PDE I, de même qu'à l'utilisation de sels pharmacologiquement compatibles de ces composés pour l'administration locale ou par voie générale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of pde inhibitors in the manufacture of a medicament for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pde inhibitors in the manufacture of a medicament for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pde inhibitors in the manufacture of a medicament for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1750606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.